Edmond Fleischer

420 total citations
24 papers, 351 citations indexed

About

Edmond Fleischer is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Edmond Fleischer has authored 24 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Edmond Fleischer's work include Drug Transport and Resistance Mechanisms (5 papers), Cancer therapeutics and mechanisms (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Edmond Fleischer is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Cancer therapeutics and mechanisms (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Edmond Fleischer collaborates with scholars based in Germany, China and Sudan. Edmond Fleischer's co-authors include Anette Klinger, Thomas Efferth, Sara Abdelfatah, Brian C. Monk, Mikhail V. Keniya, Richard D. Cannon, Mona Dawood, Sami Hamdoun, Onat Kadioglu and Letian Shan and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Edmond Fleischer

24 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edmond Fleischer Germany 13 206 97 58 51 45 24 351
Anette Klinger Germany 13 217 1.1× 102 1.1× 56 1.0× 67 1.3× 43 1.0× 20 362
Yangyang Zhai China 12 281 1.4× 74 0.8× 58 1.0× 51 1.0× 26 0.6× 29 427
Opeyemi Soremekun South Africa 14 178 0.9× 47 0.5× 38 0.7× 50 1.0× 36 0.8× 61 468
Nivedita Bhardwaj India 11 153 0.7× 78 0.8× 26 0.4× 85 1.7× 64 1.4× 37 483
Weifan Jiang China 11 258 1.3× 60 0.6× 21 0.4× 69 1.4× 29 0.6× 34 441
Yingna Cai United States 7 162 0.8× 56 0.6× 50 0.9× 62 1.2× 34 0.8× 9 359
Li Liang China 11 185 0.9× 48 0.5× 70 1.2× 38 0.7× 29 0.6× 38 374
Chien-Fu Huang Taiwan 12 225 1.1× 59 0.6× 30 0.5× 32 0.6× 125 2.8× 22 495
Dhanir Tailor United States 11 273 1.3× 78 0.8× 24 0.4× 55 1.1× 42 0.9× 29 441
Himanshu Verma India 14 213 1.0× 69 0.7× 24 0.4× 133 2.6× 33 0.7× 44 552

Countries citing papers authored by Edmond Fleischer

Since Specialization
Citations

This map shows the geographic impact of Edmond Fleischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edmond Fleischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edmond Fleischer more than expected).

Fields of papers citing papers by Edmond Fleischer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edmond Fleischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edmond Fleischer. The network helps show where Edmond Fleischer may publish in the future.

Co-authorship network of co-authors of Edmond Fleischer

This figure shows the co-authorship network connecting the top 25 collaborators of Edmond Fleischer. A scholar is included among the top collaborators of Edmond Fleischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edmond Fleischer. Edmond Fleischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keniya, Mikhail V., A. Sagatova, Christoph Müller, et al.. (2024). The Molecular Basis of the Intrinsic and Acquired Resistance to Azole Antifungals in Aspergillus fumigatus. Journal of Fungi. 10(12). 820–820. 7 indexed citations
2.
Lu, Xiaohua, Sebastian Blatt, Mona Dawood, et al.. (2022). Novel artemisinin derivative FO8643 with anti-angiogenic activity inhibits growth and migration of cancer cells via VEGFR2 signaling. European Journal of Pharmacology. 930. 175158–175158. 8 indexed citations
3.
4.
Mahmoud, Nuha, Mohamed‐Elamir F. Hegazy, Walaa Wadie, et al.. (2022). Naphthoquinone derivatives as P-glycoprotein inducers in inflammatory bowel disease: 2D monolayers, 3D spheroids, and in vivo models. Pharmacological Research. 179. 106233–106233. 14 indexed citations
5.
Lu, Xiaohua, Mohamed Elbadawi, Sebastian Blatt, et al.. (2022). Artemisinin derivative FO-ARS-123 as a novel VEGFR2 inhibitor suppresses angiogenesis, cell migration, and invasion. Chemico-Biological Interactions. 365. 110062–110062. 8 indexed citations
6.
Kadioglu, Onat, Sabine M. Klauck, Edmond Fleischer, Letian Shan, & Thomas Efferth. (2021). Selection of safe artemisinin derivatives using a machine learning-based cardiotoxicity platform and in vitro and in vivo validation. Archives of Toxicology. 95(7). 2485–2495. 12 indexed citations
7.
Fischer, Nicolas, Ean‐Jeong Seo, Sara Abdelfatah, et al.. (2021). A novel ligand of the translationally controlled tumor protein (TCTP) identified by virtual drug screening for cancer differentiation therapy. Investigational New Drugs. 39(4). 914–927. 7 indexed citations
8.
Lu, Xiaohua, Ge Yan, Mona Dawood, et al.. (2021). A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells. Biochemical Pharmacology. 194. 114677–114677. 13 indexed citations
9.
Dawood, Mona, Edmond Fleischer, Anette Klinger, et al.. (2020). Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344. Pharmacological Research. 160. 105076–105076. 14 indexed citations
10.
Mahmoud, Nuha, Mohamed E.M. Saeed, Yoshikazu Sugimoto, et al.. (2020). Putative molecular determinants mediating sensitivity or resistance towards carnosic acid tumor cell responses. Phytomedicine. 77. 153271–153271. 19 indexed citations
11.
12.
Fischer, Nicolas, Ean‐Jeong Seo, Anette Klinger, Edmond Fleischer, & Thomas Efferth. (2020). AMG900 as novel inhibitor of the translationally controlled tumor protein. Chemico-Biological Interactions. 334. 109349–109349. 7 indexed citations
13.
Dawood, Mona, Mohamed‐Elamir F. Hegazy, Mohamed Elbadawi, et al.. (2020). Vitamin K3 chloro derivative (VKT-2) inhibits HDAC6, activates autophagy and apoptosis, and inhibits aggresome formation in hepatocellular carcinoma cells. Biochemical Pharmacology. 180. 114176–114176. 13 indexed citations
14.
Abdelfatah, Sara, Maitane Asensio, Onat Kadioglu, et al.. (2020). Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells. Phytomedicine. 86. 153196–153196. 42 indexed citations
15.
Weber, Anja, Michele Bonus, Edmond Fleischer, et al.. (2019). Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5. Frontiers in Pharmacology. 10. 400–400. 18 indexed citations
16.
Abdelfatah, Sara, Edmond Fleischer, Anette Klinger, Vincent Kam Wai Wong, & Thomas Efferth. (2019). Identification of inhibitors of the polo-box domain of polo-like kinase 1 from natural and semisynthetic compounds. Investigational New Drugs. 38(1). 1–9. 10 indexed citations
17.
Hegazy, Mohamed‐Elamir F., Masashi Fukaya, Mona Dawood, et al.. (2019). Vitamin K3 thio-derivative: a novel specific apoptotic inducer in the doxorubicin-sensitive and -resistant cancer cells. Investigational New Drugs. 38(3). 650–661. 13 indexed citations
18.
Abdelfatah, Sara, Angela Berg, Qi Huang, et al.. (2019). MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate. Acta Pharmaceutica Sinica B. 9(5). 1021–1034. 30 indexed citations
19.
Hamdoun, Sami, Edmond Fleischer, Anette Klinger, & Thomas Efferth. (2017). Lawsone derivatives target the Wnt/β-catenin signaling pathway in multidrug-resistant acute lymphoblastic leukemia cells. Biochemical Pharmacology. 146. 63–73. 25 indexed citations
20.
Keniya, Mikhail V., Edmond Fleischer, Anette Klinger, Richard D. Cannon, & Brian C. Monk. (2015). Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance. PLoS ONE. 10(5). e0126350–e0126350. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anette Klinger Breakdown of academic impact, for papers by Yangyang Zhai Breakdown of academic impact, for papers by Opeyemi Soremekun Breakdown of academic impact, for papers by Nivedita Bhardwaj Breakdown of academic impact, for papers by Weifan Jiang Breakdown of academic impact, for papers by Yingna Cai Breakdown of academic impact, for papers by Li Liang Breakdown of academic impact, for papers by Chien-Fu Huang Breakdown of academic impact, for papers by Dhanir Tailor Breakdown of academic impact, for papers by Himanshu Verma
Rankless by CCL
2026